NYSE: MPW

Medical Properties Trust Inc Stock Forecast, Predictions & Price Target

The consensus among 7 Wall Street analysts covering (NYSE: MPW) stock is to Hold MPW stock.

Out of 7 analysts, 1 (14.29%) are recommending MPW as a Strong Buy, 1 (14.29%) are recommending MPW as a Buy, 2 (28.57%) are recommending MPW as a Hold, 1 (14.29%) are recommending MPW as a Sell, and 2 (28.57%) are recommending MPW as a Strong Sell.

If you're new to stock investing, here's how to buy Medical Properties Trust stock.

(NYSE: MPW) Medical Properties Trust's forecast annual revenue growth rate of -0.23% is not forecast to beat the US REIT - Healthcare Facilities industry's average forecast revenue growth rate of 5.38%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 7.66%.

Medical Properties Trust's revenue in 2023 is $1,374,668,000.On average, 5 Wall Street analysts forecast MPW's revenue for 2023 to be $805,215,334,000, with the lowest MPW revenue forecast at $799,491,290,000, and the highest MPW revenue forecast at $820,522,180,000. On average, 5 Wall Street analysts forecast MPW's revenue for 2024 to be $825,961,100,000, with the lowest MPW revenue forecast at $794,992,800,000, and the highest MPW revenue forecast at $856,330,400,000.

In 2025, MPW is forecast to generate $810,491,925,000 in revenue, with the lowest revenue forecast at $748,750,000,000 and the highest revenue forecast at $878,733,000,000.

According to 7 Wall Street analysts that have issued a 1 year MPW price target, the average MPW price target is $7.21, with the highest MPW stock price forecast at $10.00 and the lowest MPW stock price forecast at $4.00.

On average, Wall Street analysts predict that Medical Properties Trust's share price could reach $7.21 by Nov 29, 2024. The average Medical Properties Trust stock price prediction forecasts a potential upside of 53.82% from the current MPW share price of $4.69.

(NYSE: MPW) forecast ROE is N/A, which is considered weak.